GW Pharma CEO on new cannabis-derived drug
GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says about the future of cannabis-derived drugs.
Cannabis stocks surge on legalization hopes — Here’s why
Vivien Azer, Cowen and Company, joins ‘Power Lunch’ to discuss the surge in cannabis stocks as investors anticipate legalization if there is a Biden presidency. Subscribe to CNBC PRO for…
Recreational pot now legal in Illinois—What it means for cannabis sector
Pot is now legal in Illinois. Charlie Bachtell, Cresco Labs CEO, joins CNBC’s “Power Lunch” team to discuss the cannabis sector. Illinois rings in the new year on Wednesday by…
New Aurora Cannabis CEO on the U.S. and Canada cannabis markets
Miguel Martin, the newly appointed Aurora Cannabis CEO, joins ‘Power Lunch’ to discuss his thoughts on the U.S. and Canada cannabis markets and if he thinks marijuana could be legalized…
Here are some of the women breaking into the cannabis industry
More women are entering the cannabis industry. CNBC’s Frank Holland reports on the numbers and the women breaking into the space. For access to live and exclusive video from CNBC…